St. Jude Would Complete DES/CRT Trinity; Does Conor Need IP Absolution?
This article was originally published in The Gray Sheet
Executive Summary
Conor Medsystems may realize a legal benefit from Boston Scientific's newly acquired right to sublicense the use of paclitaxel on coronary stents